Indole derivatives or benzimidazole derivatives for modulating IκB kinase

US7285560B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Olaf Ritzeler · Bad Soden, DE
• Gerhard Jaehne · Frankfurt, DE

Key dates

• Filing date: Aug 18, 2003
• Grant date: Oct 23, 2007
• Expiry date: Jul 4, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to indole derivatives or benzimidazole derivatives, to processes for preparing such compounds, to pharmaceutical compositions comprising such compounds, and methods for the prophylaxis and therapy of a disease associated with an increased activity of IκB kinase comprising administering such compounds.